New Key Statistics Module, Z-Score and F-Score
AMEX:ATNM Key Ratios
| Market Cap $ M | 260.01 |
| Enterprise Value $ M | 177.94 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.85 |
| Price/Sales | 2,910.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.71 |
| Beneish M-Score | -2.91 |
| 10-y EBITDA Growth Rate % | 27.30 |
| 5-y EBITDA Growth Rate % | 25.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.56 |
| EV-to-EBITDA | -3.62 |
| PEG | -- |
| Shares Outstanding M | 29.78 |
| Net Margin (%) | -57,346.91 |
| Operating Margin % | -61,645.68 |
| Pre-tax Margin (%) | -57,346.91 |
| Quick Ratio | 10.59 |
| Current Ratio | 10.59 |
| ROA % (ttm) | -50.51 |
| ROE % (ttm) | -99.21 |
| ROIC % (ttm) | -1,304.62 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.66 |
ATNM Number of Guru Trades
ATNM Volume of Guru Trades
Gurus Latest Trades with AMEX:ATNM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:ATNM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Actinium Pharmaceuticals Inc Insider Transactions
No Available Data
News about AMEX:ATNM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers